Octostim (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim, is a synthetic analog of the natural hormone vasopressin presented as a tablet for oral use. It is employed to manage conditions related to water balance and certain bleeding disorders in both children and adults.

GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Desmopressin Acetate is used in disorders that involve antidiuretic hormone pathways or coagulation factor deficiencies. - Central diabetes insipidus: helps control excessive urine output and thirst. - Nocturnal enuresis: reduces nighttime bedwetting episodes in children. - Mild hemophilia A and von Willebrand disease: raises plasma levels of factor VIII and von Willebrand factor to improve clotting.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal congestion or irritation (if administered nasally). - Nausea or abdominal discomfort. - Hyponatraemia: low blood sodium, usually mild. - Flushing or warmth sensation.

Serious or Rare Side Effects: - Severe hyponatraemia leading to seizures or coma. - Thrombotic events such as deep‑vein thrombosis. - Allergic reactions including rash, itching or anaphylaxis. - Hypertension or significant blood‑pressure rise. - Cardiac arrhythmias in patients with electrolyte imbalance.

Desmopressin should be used with careful clinical oversight, particularly in patients at risk of fluid overload or electrolyte disturbance. - Fluid restriction: limit intake to avoid hyponatraemia. - Monitor sodium: regular blood‑sodium checks during therapy. - Cardiovascular disease: use cautiously in hypertension or heart failure. - Pregnancy and lactation: assess risk‑benefit, as safety data are limited. - Concomitant anticoagulants: evaluate bleeding risk when used together. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Desmopressin can interact with several medicines that affect fluid balance, coagulation or blood pressure.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): increase risk of hyponatraemia. - Carbamazepine: may reduce desmopressin effectiveness. - Antidiuretic‑type drugs (e.g., chlorpropamide): additive water‑retention effect.

Moderate Interactions (Monitor Closely): - Warfarin or other oral anticoagulants: may enhance bleeding control but require INR monitoring. - ACE inhibitors or ARBs: potential for exaggerated blood‑pressure changes. - Diuretics (especially thiazides): alter sodium balance, needing closer electrolyte surveillance.